» Authors » Robert Ollinger

Robert Ollinger

Explore the profile of Robert Ollinger including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 140
Citations 1712
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiering L, Aigner A, van Rosmalen M, Globke B, Dziodzio T, Raschzok N, et al.
Transpl Int . 2025 Feb; 38:13844. PMID: 39944216
In liver allocation systems based on the Model for End-stage Liver Disease (MELD) score, sex inequities have been identified in countries with high organ donation rates. Whether similar inequities exist...
2.
Saidy R, Eurich F, Globke B, Schoning W, Ollinger R, Raschzok N, et al.
Viruses . 2025 Jan; 16(12. PMID: 39772140
Introduction: The development of chronic kidney disease (CKD) is a common and significant complication, contributing to morbidity after liver transplantation (LT). Cytomegalovirus (CMV) infection is common in the overall population,...
3.
Stronisch A, Rau D, Wittenberg S, Kaul D, Koulaxouzidis G, Ollinger R, et al.
Int J Cancer . 2024 Oct; 156(4):802-816. PMID: 39415509
Centralising soft tissue sarcoma (STS) treatment in expert centres and implementing comprehensive therapy concepts through interdisciplinary tumour boards (ITB) has led to significant treatment progress. However, our knowledge on the...
4.
Reichelt S, Ollinger R, Halleck F, Kahl A, Raschzok N, Winter A, et al.
J Clin Med . 2024 Sep; 13(17). PMID: 39274392
: Pancreas transplantation (PTX) remains the most effective treatment to prevent long-term complications and provide consistent euglycemia in patients with endocrine pancreatic insufficiency, mainly in type I diabetic patients. Considering...
5.
Moosburner S, Patel M, Wang B, Prasadh J, Ollinger R, Lurje G, et al.
Ann Surg . 2024 Aug; 280(5):896-904. PMID: 39140592
Objective: To evaluate the outcome of marginal liver grafts based on the Eurotransplant extended criteria donor (ECD) criteria. Background: Eurotransplant uses a broad definition of ECD criteria (age >65 years,...
6.
Schrezenmeier E, Choi M, Globke B, Dorner T, Leimbach A, Osmanodja B, et al.
Transfus Med Hemother . 2024 Jun; 51(3):158-163. PMID: 38867806
Introduction: The transplantation of highly sensitized patients remains a major obstacle. Immunized patients wait longer for a transplant if not prioritized, and if transplanted, their transplant outcome is worse. Case...
7.
Moosburner S, Kettler C, Hillebrandt K, Blank M, Freitag H, Knitter S, et al.
Ann Surg Open . 2023 Dec; 4(4):e350. PMID: 38144486
Objective: To compare the outcome of minimally invasive liver surgery (MILS) to open liver surgery (OLS) for resection of colorectal liver metastases (CRLM) on a nationwide level. Background: Colorectal cancer...
8.
Saidy R, Kollar S, Czigany Z, Dittrich L, Raschzok N, Globke B, et al.
Transpl Infect Dis . 2023 Nov; 26(1):e14196. PMID: 38010975
Introduction: Cytomegalovirus (CMV)-infection and reactivation remain a relevant complication after liver transplantation (LT). The recipient and donor serum CMV-IgG-status has been established for risk stratification when choosing various pharmaceutical regimens...
9.
Primavesi F, Maglione M, Cipriani F, Denecke T, Oberkofler C, Starlinger P, et al.
Br J Surg . 2023 Aug; 110(10):1331-1347. PMID: 37572099
Background: Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus...
10.
Roohani S, Ehret F, Kobus M, Florcken A, Mardian S, Rau D, et al.
Adv Radiat Oncol . 2023 May; 8(4):101224. PMID: 37213480
Purpose: Radiotherapy (RT) is a mainstay of treatment for high-grade soft tissue sarcomas (STS). We sought to examine the pattern of local recurrence (LR) with regard to target volume, clinical...